SYRE — Spyre Therapeutics Inc
In 2026 Q2, 4 of the 140 tracked hedge funds reported a position in Spyre Therapeutics Inc (SYRE), worth $174.50M combined. Over the quarter 2 opened or added, 2 trimmed or exited.
Hedge fund holders, 2026 Q2
| Fund | Value | Portfolio % | Change |
|---|---|---|---|
| Polar Capital | $87.72M | 0.25% | +24.6% |
| Emerald | $50.38M | 1.20% | -7.5% |
| Emerald Mutual | $35.62M | 1.30% | -1.7% |
| Persistent | $777.71K | 0.25% | +82.4% |
All stocks · Quarterly Trends · Hedge Fund Tracker
Source: SEC EDGAR 13F filings, reported as of quarter end and filed up to 45 days later. Not investment advice.